Case Report: Multidisciplinary management of toxic epidermal necrolysis in an elderly critically ill patient with multidrug exposure and concurrent MRSA pneumonia
Toxic epidermal necrolysis (TEN) is a life-threatening severe cutaneous adverse reaction whose management becomes particularly difficult in older critically ill patients with polypharmacy and active infection. We report a 74-year-old man with long-term ibuprofen exposure who was admitted for severe upper gastrointestinal bleeding and subsequently developed methicillin-resistant Staphylococcus aureus (MRSA) pneumonia requiring sequential antimicrobial therapy. During hospitalization, progressively confluent erythematous lesions evolved into bullae, erosions, and epidermal detachment, and TEN was diagnosed clinically after transfer to a specialized burn unit. Potentially causative medications were withdrawn or modified as clinically feasible. The patient underwent multidisciplinary management comprising supportive care, specialized wound management, susceptibility-guided anti-infective therapy, intravenous immunoglobulin (IVIG) at 20 g/day for 5 days, and systemic methylprednisolone followed by tapering. Dongju lotion, a traditional Chinese medicine preparation used in the burn unit, was applied only as an adjunctive wound-bathing and cleansing measure. The cutaneous lesions subsequently ceased to progress, exudation decreased, and the erosive surfaces gradually re-epithelialized. Before discharge, most wounds had healed, with approximately 5% of the total body surface area remaining unhealed, while the concurrent infection was controlled. Unlike recent TEN reports centered on a single identifiable trigger or nursing protocol, this case highlights therapeutic decision-making under diagnostic and treatment uncertainty in an elderly patient with multiple potential culprit drugs, active MRSA pneumonia, recent major gastrointestinal bleeding, and competing risks from immunomodulation. The favorable course should be attributed to the overall multidisciplinary strategy rather than to any individual intervention.
Authors
- Lijiao You (ORCID: https://orcid.org/0000-0003-0957-0109)
- Jialei Meng
- Ming Lei (ORCID: https://orcid.org/0000-0002-8099-7095)
- Wenjun Cai (ORCID: https://orcid.org/0000-0002-8205-3346)
- Yaoguo Han (ORCID: https://orcid.org/0009-0000-2089-6746)
- Haikuo Wang (ORCID: https://orcid.org/0009-0003-8010-9355)
- Wentao Feng
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Integrated Chinese Medicine (China) (HK)
- Shanghai Traditional Chinese Medicine Hospital (CN)
- Seventh People's Hospital of Shanghai (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fmed.2026.2021066
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00